Kingmed Diagnostics(SH:603882) 2 1 Shi Ji Jing Ji Bao Dao·2024-02-22 01:24Core Viewpoint - The medical industry is at the forefront of the technological revolution driven by artificial intelligence (AI), with companies like Kingmed Diagnostics leading the transformation towards digitalization and AI integration in medical testing services [1][2]. Industry Overview - Guangdong province is positioning itself as a leader in the medical testing industry, with a focus on high-quality development and digital transformation [1]. - The medical testing service industry in Guangdong has achieved a leading position in revenue, service types, sample testing volume, and population coverage nationwide [1]. AI Integration in Medical Testing - AI is becoming a core driver of change in the medical testing industry, enhancing diagnostic precision and addressing issues like resource shortages and uneven distribution of medical services [2][4]. - Kingmed Diagnostics has developed multiple AI-assisted pathology diagnostic products and established a remote pathology collaboration network covering over 15,000 grassroots hospitals [2][3]. Digital Transformation Initiatives - Kingmed Diagnostics initiated its digital transformation in 2020, focusing on big data mining and AI-assisted diagnostics across various operational areas [2][5]. - The company has collaborated with major tech firms like Huawei and Tencent to develop AI models that improve diagnostic efficiency, such as a cervical cytology AI screening model that has been used over 1.2 million times, increasing efficiency by over 40% [3][4]. Challenges and Opportunities - The third-party medical testing industry in China benefits from a large sample size, which is crucial for discovering new disease patterns and establishing standards [4]. - The main challenge lies in the integration of digital technologies and the need for interdisciplinary talent who understand both life sciences and AI [4][5]. Ecosystem Development - Guangdong's medical testing industry benefits from a well-established industrial ecosystem, with numerous in vitro diagnostic and medical device companies contributing to innovation [5][6]. - Kingmed Diagnostics has developed over 4,000 medical testing projects, with significant growth in areas such as genetic and rare diseases, and infectious diseases, all exceeding 30% growth in the first three quarters of 2023 [5][6]. Collaborative Models - Kingmed Diagnostics has established an innovation management system that links technology research, product development, and clinical application through partnerships with over 190 institutions [5][6]. - The company aims to enhance collaboration across the supply chain, focusing on co-development of equipment and reagents to improve the overall medical testing ecosystem [6][7].